
|Videos|November 15, 2020
AAO: Medication could reduce burden of steroid drops for patients
Author(s)OTE Staff Reports
Cynthia Matossian, MD, FACS, ABES, presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
Advertisement
Cynthia Matossian, MD, FACES, ABES, of Matossian Eye Associates, presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
The study examined early experiences among cataract surgeons with the use of the injectabcle ophthalmic anti-inflammatory medications.Cynthia Matossian, MD, FACS, ABES presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
RCA releases first State of Retina Care report
2
OT Roundup ep. 1: ADHD's eye link, MOGENRY's BLA, and myopia news
3
FAQ: What retina specialists need to know about the MOGENRY (MCO-010) BLA acceptance
4
Vienna calling: Inside the 26th EURETINA Congress
5








